Skip to main content

Vasculitis

      My favorite three presentations from day 4 at ACR 2021 included the following: Breakthrough Infections in Rheumatic Disease Patients Late-Breaking Abstract L16 - Dr. Jazvinder Singh presented the…
      RT @GuyKatzMD: 📢No difference in ESRD or mortality with RTX-based vs CYC-based induction regimen in ANCA #Vasculitis
      3 years 1 month ago
      📢No difference in ESRD or mortality with RTX-based vs CYC-based induction regimen in ANCA #Vasculitis #ACR21 https://t.co/Bdz5t2uyHi
      RT @ERheumat: #ACR21 #ACR2021 Clinical Pearls
      🚨 Thread Alert
      1/n
      💥AAV does not typically cause hard palate lesio
      3 years 1 month ago
      #ACR21 #ACR2021 Clinical Pearls 🚨 Thread Alert 1/n 💥AAV does not typically cause hard palate lesions➡️consider: Cocaine induced midline destructive lesion(HNE+)/Malignancy 💥Limited GPA can be ANCA negetive in 50% 💥 oral cavity examination is a must in Rheum https://t.co/RxkLiGdcJt
      RT @ericdeinmd: #ACR21 TM24. Hydralazine-induced ANCA vasculitis presenting with chondritis.
      Labs:
      +ANA
      +Anti-histone
      +
      3 years 1 month ago
      #ACR21 TM24. Hydralazine-induced ANCA vasculitis presenting with chondritis. Labs: +ANA +Anti-histone +p-ANCA, +MPO and +PR3 @Rheumnow https://t.co/YQvqj0vCHp https://t.co/LPyVYYzLtI
      RT @ericdeinmd: #ACR21 2022 ACR/EULAR GPA Criteria
      ▶️Classification, NOT diagnostic!
      ⭐️Clinical, lab, imaging, a
      3 years 1 month ago
      #ACR21 2022 ACR/EULAR GPA Criteria ▶️Classification, NOT diagnostic! ⭐️Clinical, lab, imaging, and biopsy criteria ⭐️+5 pts for cANCA or PR3, negative pts for pANCA or MPO, or eosinophilia @RheumNow https://t.co/6YWmabNzuH https://t.co/vg8zaFt5dR
      RT @EBRheum: ACR/EULAR Classification Criteria for ANCA vasculitis, updated from prior

      Similar disclaimer; these are f
      3 years 1 month ago
      ACR/EULAR Classification Criteria for ANCA vasculitis, updated from prior Similar disclaimer; these are for use AFTER the diagnosis of small or medium vasculitis has been made Great international effort, kudos to all involved #ACR21 #ACRambassador https://t.co/a29TVvzVF7
      RT @ERheumat: #ACR21
      new 2022 classification criteria by ACR/EULAR for AAV
      💥GPA-Sensitivity-92%, Specificity-94%
      ðŸ’
      3 years 1 month ago
      #ACR21 new 2022 classification criteria by ACR/EULAR for AAV 💥GPA-Sensitivity-92%, Specificity-94% 💥MPA-Sensitivity-91%, Specificity-94% 💥EGPA-Sensitivity-85%, Specificity-99% 💥Score based https://t.co/61SOl4Tovg
      What's Cool and Hot in Vasculitis: Dr. Janet Pope reviews abstracts #0505, #0466, #0430, #0507 and #0504, being presente
      3 years 1 month ago
      What's Cool and Hot in Vasculitis: Dr. Janet Pope reviews abstracts #0505, #0466, #0430, #0507 and #0504, being presented at the #ACR21 annual meeting. https://t.co/7XwjFuJEMM https://t.co/BC9wjPzNC0
      RT @ericdeinmd: #ACR21 2022 ACR/EULAR MPA Criteria
      ▶️Classification, NOT diagnostic!
      ⭐️Clinical: negative for na
      3 years 1 month ago
      #ACR21 2022 ACR/EULAR MPA Criteria ▶️Classification, NOT diagnostic! ⭐️Clinical: negative for nasal GPA symptoms ⭐️Lab: +6 for pANCA or MPO, negative for cANCA/PR3 or eosinophilia @RheumNow https://t.co/6YWmabNzuH https://t.co/XVzBF2KONp
      ×